Delivery Order SPE2DB24D3013-SPE2DB26FFFSL
- Not listed
- The Defense Logistics Agency awarded a $7,430.01 delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for RINVOQ ER 15 mg tablets (30-count units), with completion scheduled for November 3, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with the DLA. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at approximately $25,052 to AmerisourceBergen Drug Corp for the supply of RINVOQ ER 15 mg tablets (30-count units). This firm fixed-price, competitively awarded contract was executed on October 28, 2025, with an ultimate completion date of October 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $12,497.80 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on August 11, 2025, with an ultimate completion date of August 12, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $10,017.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count units). This is a non-set-aside competitive award with an ultimate completion date of October 28, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $77,809.56 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 27, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $23,362.75 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for RINVOQ ER 45 mg tablets (28-count units). This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania facility,...
- The Defense Logistics Agency awarded a $197,052.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for RINVOQ ER 15 mg tablets (30-count units). This is a non-set-aside competitive award with an ultimate completion date of September 18, 2025, to be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $10,071.36 delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for RINVOQ ER 15 mg tablets (30-count units), with completion scheduled for October 24, 2025. This firm fixed-price contract represents a non-competitive delivery order, with performance occurring at the contractor's Conshohocken, Pennsylvania facility. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $14,468.30 delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 MG tablets (30-count units) on October 29, 2025, with an ultimate completion date of October 30, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $30,275.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on August 15, 2025, with an ultimate completion date of August 18, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order will be performed...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB26FFFSLDelivery Order
The Defense Logistics Agency awarded a $6,355.55 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count units). This is a non-set-aside, competitively awarded contract with an ultimate completion date of October 22, 2025, and performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The SPE2DX prime contract vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products, specialty medications, brand-name and generic drugs, vaccines, and medical supplies to support military healthcare programs globally. This delivery order for RINVOQ, a rheumatoid arthritis treatment, exemplifies the company's role in fulfilling diverse pharmaceutical requirements across the Defense Health Agency and other federal healthcare systems through flexible contracting mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.4k | 10/21/25 |